TickerFacts.

Valion Bio, Inc. (VBIO): Revenue

Annual figures by period end, from SEC filings.

$780.0K
Year ended 2024-12-31
-14.7%
3-year compound annual growth
$1.84M2021-12-31: $1.26M2022-12-31: $1.84M2023-12-31: $1.18M2024-12-31: $780.0K$780.0K
2021-12-31 Revenue (USD) 2024-12-31
Period endedRevenueChange YoYSource filing
2024-12-31$780.0K-33.7%2025-03-21, From 2024-01-01
2023-12-31$1.18M-36.1%2025-03-21, From 2023-01-01
2022-12-31$1.84M+46.4%2024-03-25, From 2022-01-01
2021-12-31$1.26Mn/a2023-03-31, From 2021-01-01